Improvement in double-lumen catheter usage could provide lasting, user
friendly angioaccess for patients on hemodialysis (HD), especially th
ose on home HD. These catheters are routinely locked with concentrated
heparin at the end of an HD session, in a volume corresponding to the
lumen capacity. At the start of the next HD session, this heparin is
aspirated with a small amount of blood and discarded. The cumulative b
lood loss over a long period becomes significant. The authors aimed to
study whether a predetermined loading dose of heparin could be used t
o lock the catheter, and be administered as such during the next HD se
ssion. Thirteen patients were evaluated during four HD sessions (Rx 1
through 4; Rx 4 followed a weekend). Prior to the first study HD (Rx 1
), the catheter was locked with 10,000 units heparin per lumen, as per
our standard practice. Therefore, Rx 1 was considered the standard fo
r the purpose of the study. On study HD (Rx 1 through 4), the catheter
was locked with the patient's loading dose (half per lumen). The hepa
rin loading dose was given as follows: Rx 1 and 2 = fresh heparin; Rx
3 and 4 = locked heparin. Again, activated clotting time (ACT) was mea
sured periodically and heparin was given according to an ACT-based sli
ding scale. The first ACT and heparin level (drawn after the loading d
ose) were compared for Rx 1 rs Rx 2, 3, and 4. The mean (+/- SEM) valu
es were as follows: Rx 1 - first ACT = 299.2 +/- 16.5 sec, heparin lev
el = 1.25 +/- 0.15 IU/ml; Rx 2 - first ACT = 305 +/- 20 sec, heparin l
evel = 1.1 +/- 0.09 IU/ml; Rx 4 - first ACT = 293 +/- 18.5 sec, hepari
n level = 1.1 +/- 0.19 IU/ml; and Rx 4 - first ACT = 288 +/- 24.1 sec,
heparin level = 1.07 +/- 0.16 IU/ml. The mean of the differences betw
een Rw 1 and Rx 2, 3, and 4, were not significantly different for all
of the analyzed parameters. No catheter was lost during the study peri
od. The results suggest that locked heparin can be effectively used as
the loading dose. Advantages of this method include decreased blood w
astage, heparin cost savings corresponding to the cost of concentrated
heparin (approximately $156.00 per patient year for HD three time wee
kly), and at least one less connection per catheter lumen. The latter
would possibly reduce the risk of transluminal catheter related infect
ions.